Tonix Pharmaceuticals (TNXP) Misses Q2 EPS by 8c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Goldman "broadly" raises estimates for LTL and truckload stocks
• BofA lists top 5 themes driving next $1tn in incremental semi sales